Research: diabetes news
Research and clinical studies that help us better understand diabetes: from genetics and microbiota to new therapies in trial stages.
Weight loss doesn't always prevent type 2 diabetes, new study finds
A German study found that even after maintaining 8% weight loss for 9 years, a group of people at high metabolic risk still saw their blood glucose rise and their insulin secretion fall.
Read more →The 2026 update for cardiologists prioritizes cardiorenal benefit when choosing type 2 diabetes treatment
The latest review reinforces a shift in approach: choosing drugs based on their cardiovascular and kidney benefit, even when glucose control is already acceptable.
Read more →A biochemical blood signature identifies people at higher risk of dying from diabetes
Researchers from the URV, IRB-CatSud and CIBEROBN have identified 9 blood metabolites, common to both type 2 diabetes and insulin resistance, associated with a higher risk of death.
Read more →An AI model predicts hospital hypoglycemia 24 hours in advance
Cedars-Sinai researchers developed an LSTM AI model that, using data from nearly 143,000 hospital admissions, predicts which patients are at risk of hypoglycemia up to 24 hours before it happens.
Read more →Why type 2 diabetes is increasingly understood as an inflammatory disease too
There's growing consensus that, beyond a glucose regulation problem, type 2 diabetes involves chronic low-grade inflammation that feeds back into insulin resistance.
Read more →Gut microbiota, a new clue to understanding type 2 diabetes
Researchers identify a link between microbiota composition and glucose metabolism regulation.
Read more →A low-calorie Mediterranean diet combined with exercise cuts type 2 diabetes risk by 31%
The PREDIMED-Plus clinical trial, involving 4,746 adults with overweight or obesity and metabolic syndrome across more than 100 primary care centers in Spain, found a 31% reduction in type 2 diabetes risk with a low-calorie Mediterranean diet, moderate exercise and ongoing professional support.
Read more →Gene therapy: a clinical trial aims to teach muscles to regulate glucose
Biotech company Kriya Therapeutics introduces insulin and glucokinase genes into skeletal muscle through a single intramuscular injection.
Read more →Stem cells without immunosuppression: Sana Biotechnology starts a phase 1 trial
The biotech company is advancing a stem-cell-derived cell therapy that aims to avoid the use of immunosuppressive drugs.
Read more →A large study links semaglutide to lower kidney and cardiovascular risk
A trial with more than 3,500 participants observed a 24% reduction in a composite of serious kidney events and cardiovascular death.
Read more →A project generates insulin-producing cells from human skin for type 1 diabetes
Research co-funded by the DiabetesCERO Foundation has managed to generate, from human skin, cells increasingly similar to the pancreas's beta cells, capable of producing insulin.
Read more →